1:500) or mouse anti-DNA (Progen, 61014
High levels indicate chronic inflammation Serum ferritin: The ideal range is between 50-150
Weeks 1 to 4 (loading phase): TB-500: 2.5 mg subcutaneous, twice weekly GHK-Cu (injectable, if prescribed): 1 mg subcutaneous, three times weekly GHK-Cu (topical, over wound or scar): 2% cream once daily Weeks 5 to 8 (maintenance phase): TB-500: 2 mg subcutaneous, once weekly GHK-Cu (injectable): 0.5 mg subcutaneous, twice weekly GHK-Cu (topical): continued as tolerated Weeks 9 to 12 (taper and assess): TB-500: 2 mg subcutaneous, once every two weeks GHK-Cu (injectable): discontinue or continue at 0.5 mg once weekly based on clinical response GHK-Cu (topical): continue indefinitely if cosmetic goal is active A 12-week total cycle is the most common practitioner-reported duration
Specific transcription factors susceptible to cellular hypoxia are known as hypoxia-inducible factors (HIFs), which include three subunits (HIF1A/HIF1, EPAS1/HIF2, HIF3A/HIF3, and one ARNT/HIF1 subunit)